BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15086603)

  • 1. Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: randomized controlled trial.
    Tomikawa M; Shimabukuro R; Okita K; Tsutsumi N; Akahoshi T; Hashizume M; Sugimachi K
    J Gastroenterol Hepatol; 2004 May; 19(5):576-81. PubMed ID: 15086603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.
    Lay CS; Tsai YT; Lee FY; Lai YL; Yu CJ; Chen CB; Peng CY
    J Gastroenterol Hepatol; 2006 Feb; 21(2):413-9. PubMed ID: 16509867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding.
    Sarin SK; Wadhawan M; Agarwal SR; Tyagi P; Sharma BC
    Am J Gastroenterol; 2005 Apr; 100(4):797-804. PubMed ID: 15784021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
    Sarin SK; Lamba GS; Kumar M; Misra A; Murthy NS
    N Engl J Med; 1999 Apr; 340(13):988-93. PubMed ID: 10099140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation.
    Gheorghe C; Gheorghe L; Iacob S; Iacob R; Popescu I
    Hepatogastroenterology; 2006; 53(70):552-7. PubMed ID: 16995460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. The PROVA Study Group.
    Hepatology; 1991 Dec; 14(6):1016-24. PubMed ID: 1959848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
    Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with liver cirrhosis after endoscopic ethanol injection sclerotherapy for esophageal varices.
    Okano H; Shiraki K; Inoue H; Kawakita T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Nakano T
    Hepatogastroenterology; 2003; 50(53):1556-9. PubMed ID: 14571785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
    Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
    Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices.
    Lay CS; Tsai YT; Teg CY; Shyu WS; Guo WS; Wu KL; Lo KJ
    Hepatology; 1997 Jun; 25(6):1346-50. PubMed ID: 9185751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial.
    Shigemitsu T; Yoshida T; Harada T; Takeo Y; Nakamura H; Okita K
    Hepatogastroenterology; 2000; 47(33):733-7. PubMed ID: 10919021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A randomized placebo-controlled multicentre study of Fuzhenghuayu capsule for prevention of oesophageal variceal bleeding in patients with liver cirrhosis].
    Xiao D; Gu J; Cai H; Zhang Q; Xue D; Zhao C; Xu L
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):594-9. PubMed ID: 25243960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
    Hori S; Takaki A; Okada H; Fujiwara A; Takenaka R; Makidono C; Shiratori Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1704-9. PubMed ID: 16984593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.
    Schepke M; Kleber G; Nürnberg D; Willert J; Koch L; Veltzke-Schlieker W; Hellerbrand C; Kuth J; Schanz S; Kahl S; Fleig WE; Sauerbruch T;
    Hepatology; 2004 Jul; 40(1):65-72. PubMed ID: 15239087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension.
    Sarin SK; Gupta N; Jha SK; Agrawal A; Mishra SR; Sharma BC; Kumar A
    Gastroenterology; 2010 Oct; 139(4):1238-45. PubMed ID: 20547163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial.
    Morales GF; Pereira Lima JC; Hornos AP; Marques DL; Costa CS; Lima Pereira L; Lopes CV; Raymondi R; Marroni CA
    Hepatogastroenterology; 2007; 54(73):195-200. PubMed ID: 17419259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?
    Abraczinskas DR; Ookubo R; Grace ND; Groszmann RJ; Bosch J; Garcia-Tsao G; Richardson CR; Matloff DS; Rodés J; Conn HO
    Hepatology; 2001 Dec; 34(6):1096-102. PubMed ID: 11731997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.
    Poynard T; Calès P; Pasta L; Ideo G; Pascal JP; Pagliaro L; Lebrec D
    N Engl J Med; 1991 May; 324(22):1532-8. PubMed ID: 1674104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.